CIK 0000877860
- Large accelerated filer
NATIONAL HEALTH INVESTORS INC
Sign in to watch- Ticker
- NHI
- Exchange
- NYSE
- Industry
- Real Estate Investment Trusts
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- Operating
- EIN
- 621470956
- Phone
- +1 615-890-9100
- Business address
- 222 ROBERT ROSE DRIVE, MURFREESBORO, TN, 37129
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-23 | SWAFFORD CHARLOTTE A Director | Grant or award · Stock Option (Right to Buy) 2024 | +10,000 | 10,000 | ||
| 2024-02-23 | MCCABE ROBERT A JR Director | Grant or award · Stock Option (Right to Buy) 2024 | +10,000 | 10,000 | ||
| 2024-02-23 | Jobe James R Director | Grant or award · Stock Option (Right to Buy) 2024 | +10,000 | 10,000 | ||
| 2024-02-23 | COLDEN TRACY M J Director | Grant or award · Stock Option (Right to Buy) 2024 | +10,000 | 10,000 | ||
| 2024-02-23 | ADAMS ROBERT G Director | Grant or award · Stock Option (Right to Buy) 2024 | +10,000 | 10,000 | ||
| 2024-02-23 | ADAMS W ANDREW Director | Grant or award · Stock Option (Right to Buy) 2024 | +10,000 | 10,000 | ||
| 2023-10-01 | ADAMS ROBERT G Director | Other disposition | −85,411 | 0 | ||
| 2023-08-30 | Jobe James R Director | Purchase | +1,000 | $51.40 | $51K | 14,979 |
| 2023-05-05 | PASCOE KEVIN CARLTON Chief Investment Officer | Grant or award | +4,000 | 36,893 | ||
| 2023-05-05 | Gaines Kristin Sallee SVP/Chief Transaction Officer | Grant or award | +4,000 | 48,609 | ||
| 2023-05-05 | Spaid John L CFO/EVP Finance | Grant or award | +4,000 | 15,279.64 | ||
| 2023-05-05 | Travis David L SVP/Chief Accounting Officer | Grant or award | +4,000 | 4,000 | ||
| 2023-05-05 | Mendelsohn D. Eric CEO and President | Grant or award | +5,000 | 51,256 | ||
| 2023-02-24 | Travis David L SVP/Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) 2023 | +8,333 | 8,333 | ||
| 2023-02-24 | Travis David L SVP/Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) 2023 | +8,333 | 8,333 | ||
| 2023-02-24 | Travis David L SVP/Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) 2023 | +8,334 | 8,334 | ||
| 2023-02-24 | Spaid John L CFO/EVP Finance | Grant or award · Stock Option (Right to Buy) 2023 | +8,500 | 8,500 | ||
| 2023-02-24 | Spaid John L CFO/EVP Finance | Grant or award · Stock Option (Right to Buy) 2023 | +8,500 | 8,500 | ||
| 2023-02-24 | Spaid John L CFO/EVP Finance | Grant or award · Stock Option (Right to Buy) 2023 | +8,500 | 8,500 | ||
| 2023-02-24 | PASCOE KEVIN CARLTON Chief Investment Officer | Grant or award · Stock Option (Right to Buy) 2023 | +8,500 | 8,500 |
Page 16 of 17 · 332 trades